Analysing access to innovative cancer drugs.
The Institute of Cancer Research (ICR) have produced a report which asks how we can best harness advances in science to bring innovative drugs to patients. It is designed to help reshape the landscape for drug discovery and development – and create tomorrow’s cancer treatments.
The UK and the Republic of Ireland run the only formal national programme for liver transplantation in patients with neuroendocrine tumours, and evidence shows those transplanted ...
Ongoing variability in the supply of pancreatic enzyme replacement therapy (PERT) — particularly Creon® 25,000iu capsules — has left some people struggling to obtain their prescription. ...